Michael Bonares
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael Bonares has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Camilla Zimmermann
Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
3 shared publications - Kirsten Wentlandt
Division of Palliative Medicine, University Health Network, Toronto, Ontario, Canada
3 shared publications Adrianna Bruni
Division of Palliative Care, Department of Medicine, Ottawa Hospital, Ottawa, Ontario, Canada
2 shared publicationsChristine Lau
Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
2 shared publicationsDebbie Selby
Division of Palliative Medicine, Department of Medicine, University of Toronto, Toronto, Canada
2 shared publications- Debbie Selby
Division of Palliative Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
2 shared publications
Latest Publications
- Open Access
- 19 August 2026
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (9) , 529
Factors associated with requests for Medical Assistance in Dying (MAiD) referral among patients with amyotrophic lateral sclerosis receiving specialist palliative care
- 19 August 2026
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (9) , 529
Open AccessFactors associated with requests for Medical Assistance in Dying (MAiD) referral among patients with amyotrophic lateral sclerosis receiving specialist palliative care
- Open Access
- 18 May 2026
- Published by Springer Nature in BMC Palliative Care
- Vol. 25 (1)
Factors associated with dying in hospital awaiting palliative care admission: a retrospective cohort study
Palliative care facilities, including palliative care units (PCUs), remain underutilized with individuals dying in hospital despite having applied for admission. Historically, lower proportions of individuals with non-cancer diagnoses versus cancer diagnoses access these facilities. The study was conducted to determine the sociodemographic, functional, and clinical factors associated with dying in hospital awaiting PCU admission. This was a retrospective cohort study using routinely collected data from a clinical database supplemented with data from a chart review in a randomly selected subgroup. The cohort included individuals hospitalized at a single hospital in Toronto, Canada awaiting PCU admission between January and December 2023. Logistic regression was used to determine factors associated with dying in hospital awaiting PCU admission. In the total cohort (N = 426; median age = 78 years, 52% female), a minority had a non-cancer diagnosis (32%) and an expected prognosis of hours to days (18%). Most (87%) were admitted to the PCU. The subgroup (N = 133) had similar characteristics to the total cohort. Regression analysis in the total cohort showed that dying in hospital awaiting PCU admission was associated with a prognosis of hours to days (OR = 7.42; 95% CI = 1.87-29.42) but not with having a non-cancer diagnosis, after adjusting for sociodemographic, functional, and clinical factors. Regression analysis in the subgroup showed no significant association between dying in hospital awaiting PCU admission and being followed by a palliative care specialist or having a documented goals of care discussion before the terminal admission. In hospitalized individuals awaiting PCU admission, only a very short prognosis was associated with dying in hospital. Despite historical evidence of poor access, a non-cancer diagnosis was not associated with dying in hospital awaiting PCU admission.
- 18 May 2026
- Published by Springer Nature in BMC Palliative Care
- Vol. 25 (1)
Open AccessFactors associated with dying in hospital awaiting palliative care admission: a retrospective cohort study
Palliative care facilities, including palliative care units (PCUs), remain underutilized with individuals dying in hospital despite having applied for admission. Historically, lower proportions of individuals with non-cancer diagnoses versus cancer diagnoses access these facilities. The study was conducted to determine the sociodemographic, functional, and clinical factors associated with dying in hospital awaiting PCU admission. This was a retrospective cohort study using routinely collected data from a clinical database supplemented with data from a chart review in a randomly selected subgroup. The cohort included individuals hospitalized at a single hospital in Toronto, Canada awaiting PCU admission between January and December 2023. Logistic regression was used to determine factors associated with dying in hospital awaiting PCU admission. In the total cohort (N = 426; median age = 78 years, 52% female), a minority had a non-cancer diagnosis (32%) and an expected prognosis of hours to days (18%). Most (87%) were admitted to the PCU. The subgroup (N = 133) had similar characteristics to the total cohort. Regression analysis in the total cohort showed that dying in hospital awaiting PCU admission was associated with a prognosis of hours to days (OR = 7.42; 95% CI = 1.87-29.42) but not with having a non-cancer diagnosis, after adjusting for sociodemographic, functional, and clinical factors. Regression analysis in the subgroup showed no significant association between dying in hospital awaiting PCU admission and being followed by a palliative care specialist or having a documented goals of care discussion before the terminal admission. In hospitalized individuals awaiting PCU admission, only a very short prognosis was associated with dying in hospital. Despite historical evidence of poor access, a non-cancer diagnosis was not associated with dying in hospital awaiting PCU admission.
- Open Access
Sociodemographic factors associated with the utilisation of specialist palliative care in individuals with end-stage kidney disease: protocol for a scoping review
Introduction Individuals with end-stage kidney disease (ESKD), whether receiving dialysis or conservative care, experience high symptom burden and limited life expectancy, indicating substantial palliative care needs. Integrating palliative care into kidney care is vital for comprehensive ESKD management, but access remains uneven across sociodemographic groups. Identifying and addressing these disparities is key to ensuring equitable care and improving patient outcomes. This study aims to explore sociodemographic factors associated with specialist palliative care utilisation among people with ESKD. Methods and analysis This study protocol outlines a scoping review of peer-reviewed and grey literature using an established methodological framework by the Joanna Briggs Institute (JBI), and reporting will adhere to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. Relevant literature will be identified through a multi-database (Ovid MEDLINE, Embase, CINAHL, PsycINFO) and grey literature search strategy designed alongside a health sciences librarian. To be included, articles must involve individuals with ESKD and report on how sociodemographic factors influence access to and utilisation of specialist palliative care services. Results of the search will be screened independently by two reviewers and data from included studies will be extracted independently and in duplicate. A narrative and thematic analysis will be conducted to identify key themes related to sociodemographic influences on specialist palliative care access and utilisation among individuals with ESKD, with particular attention to differences between kidney care modalities (dialysis vs conservative care) and the extent to which intersectionality of sociodemographic factors has been examined. Ethics and dissemination Ethics approval is not required for this scoping review. Findings will be submitted for publication in a peer-reviewed journal. Results will identify patient-related factors influencing access to specialist palliative care in ESKD and remaining gaps in the literature, informing future research and policy to support equitable care.
Open AccessSociodemographic factors associated with the utilisation of specialist palliative care in individuals with end-stage kidney disease: protocol for a scoping review
Introduction Individuals with end-stage kidney disease (ESKD), whether receiving dialysis or conservative care, experience high symptom burden and limited life expectancy, indicating substantial palliative care needs. Integrating palliative care into kidney care is vital for comprehensive ESKD management, but access remains uneven across sociodemographic groups. Identifying and addressing these disparities is key to ensuring equitable care and improving patient outcomes. This study aims to explore sociodemographic factors associated with specialist palliative care utilisation among people with ESKD. Methods and analysis This study protocol outlines a scoping review of peer-reviewed and grey literature using an established methodological framework by the Joanna Briggs Institute (JBI), and reporting will adhere to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. Relevant literature will be identified through a multi-database (Ovid MEDLINE, Embase, CINAHL, PsycINFO) and grey literature search strategy designed alongside a health sciences librarian. To be included, articles must involve individuals with ESKD and report on how sociodemographic factors influence access to and utilisation of specialist palliative care services. Results of the search will be screened independently by two reviewers and data from included studies will be extracted independently and in duplicate. A narrative and thematic analysis will be conducted to identify key themes related to sociodemographic influences on specialist palliative care access and utilisation among individuals with ESKD, with particular attention to differences between kidney care modalities (dialysis vs conservative care) and the extent to which intersectionality of sociodemographic factors has been examined. Ethics and dissemination Ethics approval is not required for this scoping review. Findings will be submitted for publication in a peer-reviewed journal. Results will identify patient-related factors influencing access to specialist palliative care in ESKD and remaining gaps in the literature, informing future research and policy to support equitable care.
- Open Access
Palliative care utilisation in migrant populations: protocol for a scoping review
Introduction: Migrants are vulnerable to structural barriers that compromise their health status and simultaneously decrease their access to healthcare, including palliative care. Literature on palliative care access in migrant populations is limited by a focus on migration to high-income countries; under-representation of refugees, asylum seekers and migrant workers; and no investigation of intersectional factors. We seek to conduct a scoping review of palliative care utilisation in migrant populations, including both academic and grey literature, including articles from low- to middle-income countries and about refugees, asylum seekers and migrant workers. The review will map out what is already known and what remains unknown about palliative care utilisation in migrants; identify the factors associated with palliative care utilisation; and determine the extent to which intersectionality has been examined. Methods and analysis: This scoping review will adhere to the methodological framework developed by the Joanna Briggs Institute, and reporting will be in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews reporting guidelines. A search strategy developed by a health sciences librarian will be conducted on Ovid MEDLINE, Embase, CINAHL and PsycINFO in addition to grey literature sources up to 7 July 2025. Articles will be included if they studied migrant populations and reported on palliative care utilisation. Two independent reviewers will screen titles and abstracts and review full texts. Data extraction will be performed independently and in duplicate using a standardised, pilot-tested form. Findings will be synthesised thematically, with particular attention to countries of destination, migrant subgroups and intersectional factors. Ethics and dissemination: Since this is a scoping review and uses only previously published data, it does not require approval by a research ethics board. Findings will be disseminated as an abstract for presentation at a palliative care conference and a manuscript for publication in a peer-reviewed journal. Trial registration number: Open Science Framework (gy75v).
Open AccessPalliative care utilisation in migrant populations: protocol for a scoping review
Introduction: Migrants are vulnerable to structural barriers that compromise their health status and simultaneously decrease their access to healthcare, including palliative care. Literature on palliative care access in migrant populations is limited by a focus on migration to high-income countries; under-representation of refugees, asylum seekers and migrant workers; and no investigation of intersectional factors. We seek to conduct a scoping review of palliative care utilisation in migrant populations, including both academic and grey literature, including articles from low- to middle-income countries and about refugees, asylum seekers and migrant workers. The review will map out what is already known and what remains unknown about palliative care utilisation in migrants; identify the factors associated with palliative care utilisation; and determine the extent to which intersectionality has been examined. Methods and analysis: This scoping review will adhere to the methodological framework developed by the Joanna Briggs Institute, and reporting will be in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews reporting guidelines. A search strategy developed by a health sciences librarian will be conducted on Ovid MEDLINE, Embase, CINAHL and PsycINFO in addition to grey literature sources up to 7 July 2025. Articles will be included if they studied migrant populations and reported on palliative care utilisation. Two independent reviewers will screen titles and abstracts and review full texts. Data extraction will be performed independently and in duplicate using a standardised, pilot-tested form. Findings will be synthesised thematically, with particular attention to countries of destination, migrant subgroups and intersectional factors. Ethics and dissemination: Since this is a scoping review and uses only previously published data, it does not require approval by a research ethics board. Findings will be disseminated as an abstract for presentation at a palliative care conference and a manuscript for publication in a peer-reviewed journal. Trial registration number: Open Science Framework (gy75v).
- Open Access
- 10 September 2025
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 70 (6) , 679-690
Goal-Concordant Care in People With Amyotrophic Lateral Sclerosis Receiving Palliative Care
- 10 September 2025
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 70 (6) , 679-690
Open AccessGoal-Concordant Care in People With Amyotrophic Lateral Sclerosis Receiving Palliative Care
- Open Access
- 13 August 2025
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 86 (5) , 594-604.e1
Delivery of Palliative Care in the Last Year of Life to Individuals Receiving Maintenance Dialysis: A Population-Level Cross-Sectional Study
- 13 August 2025
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 86 (5) , 594-604.e1
Open AccessDelivery of Palliative Care in the Last Year of Life to Individuals Receiving Maintenance Dialysis: A Population-Level Cross-Sectional Study
- Open Access
Development and validation of a clinical prediction tool to estimate survival in community-dwelling adults living with dementia: a protocol
Introduction: A clinical prediction tool to estimate life expectancy in community-dwelling individuals living with dementia could inform healthcare decision-making and prompt future planning. An existing Ontario-based tool for community-dwelling elderly individuals does not perform well in people living with dementia specifically. This study seeks to develop and validate a clinical prediction tool to estimate survival in community-dwelling individuals living with dementia receiving home care in Ontario, Canada. Methods and analysis: This will be a population-level retrospective cohort study that will use data in linked healthcare administrative databases at ICES. Specifically, data that are routinely collected from regularly administered assessments for home care will be used. Community-dwelling individuals living with dementia receiving home care at any point between April 2010 and March 2020 will be included (N≈200 000). The model will be developed in the derivation cohort (N≈140 000), which includes individuals with a randomly selected home care assessment between 2010 and 2017. The outcome variable will be survival time from index assessment. The selection of predictor variables will be fully prespecified and literature/expert-informed. The model will be estimated using a Cox proportional hazards model. The model’s performance will be assessed in a temporally distinct validation cohort (N≈60 000), which includes individuals with an assessment between 2018 and 2020. Overall performance will be assessed using Nagelkerke’s R2, discrimination using the concordance statistic and calibration using the calibration curve. Overfitting will be assessed visually and statistically. Model performance will be assessed in the validation cohort and in prespecified subgroups. Ethics and dissemination: The study received research ethics board approval from the Sunnybrook Health Sciences Centre (SUN-6138). Abstracts of the project will be submitted to academic conferences, and a manuscript thereof will be submitted to a peer-reviewed journal for publication. The model will be disseminated on a publicly accessible website (www.projectbiglife.com). Trial registration number: NCT06266325 (clinicaltrials.gov).
Open AccessDevelopment and validation of a clinical prediction tool to estimate survival in community-dwelling adults living with dementia: a protocol
Introduction: A clinical prediction tool to estimate life expectancy in community-dwelling individuals living with dementia could inform healthcare decision-making and prompt future planning. An existing Ontario-based tool for community-dwelling elderly individuals does not perform well in people living with dementia specifically. This study seeks to develop and validate a clinical prediction tool to estimate survival in community-dwelling individuals living with dementia receiving home care in Ontario, Canada. Methods and analysis: This will be a population-level retrospective cohort study that will use data in linked healthcare administrative databases at ICES. Specifically, data that are routinely collected from regularly administered assessments for home care will be used. Community-dwelling individuals living with dementia receiving home care at any point between April 2010 and March 2020 will be included (N≈200 000). The model will be developed in the derivation cohort (N≈140 000), which includes individuals with a randomly selected home care assessment between 2010 and 2017. The outcome variable will be survival time from index assessment. The selection of predictor variables will be fully prespecified and literature/expert-informed. The model will be estimated using a Cox proportional hazards model. The model’s performance will be assessed in a temporally distinct validation cohort (N≈60 000), which includes individuals with an assessment between 2018 and 2020. Overall performance will be assessed using Nagelkerke’s R2, discrimination using the concordance statistic and calibration using the calibration curve. Overfitting will be assessed visually and statistically. Model performance will be assessed in the validation cohort and in prespecified subgroups. Ethics and dissemination: The study received research ethics board approval from the Sunnybrook Health Sciences Centre (SUN-6138). Abstracts of the project will be submitted to academic conferences, and a manuscript thereof will be submitted to a peer-reviewed journal for publication. The model will be disseminated on a publicly accessible website (www.projectbiglife.com). Trial registration number: NCT06266325 (clinicaltrials.gov).
- 29 October 2024
- Published by BMJ in BMJ Supportive & Palliative Care
Palliative care integration into outpatient heart failure management: pilot study
Objectives People with heart failure have palliative care needs yet services remain underused. The heart failure clinic is a potential setting for initial palliative care delivery though evidence for such services is lacking. We explored the outcomes of an embedded model of palliative medicine within a heart failure clinic. Methods We conducted a retrospective cohort study of individuals who received a palliative medicine consultation in a heart failure clinic. Descriptive statistics were used to characterise the cohort and their outcomes, and the McNemar test to compare rates of advance care planning before/after consultation. Results Majority of individuals who received a palliative medicine consultation experienced New York Heart Association (NYHA) class II symptoms (65.5%) and had a Palliative Performance Scale score of≥60% (66.8%). While only 17% engaged in advance care planning in the year before consultation, 93% had advance care planning during the first consultation (pConclusions Our embedded model of palliative medicine within the heart failure clinic was associated with increased advance care planning at a time when patients were functional and minimally symptomatic. Further research should substantiate these findings at other sites.
- 29 October 2024
- Published by BMJ in BMJ Supportive & Palliative Care
Palliative care integration into outpatient heart failure management: pilot study
Objectives People with heart failure have palliative care needs yet services remain underused. The heart failure clinic is a potential setting for initial palliative care delivery though evidence for such services is lacking. We explored the outcomes of an embedded model of palliative medicine within a heart failure clinic. Methods We conducted a retrospective cohort study of individuals who received a palliative medicine consultation in a heart failure clinic. Descriptive statistics were used to characterise the cohort and their outcomes, and the McNemar test to compare rates of advance care planning before/after consultation. Results Majority of individuals who received a palliative medicine consultation experienced New York Heart Association (NYHA) class II symptoms (65.5%) and had a Palliative Performance Scale score of≥60% (66.8%). While only 17% engaged in advance care planning in the year before consultation, 93% had advance care planning during the first consultation (pConclusions Our embedded model of palliative medicine within the heart failure clinic was associated with increased advance care planning at a time when patients were functional and minimally symptomatic. Further research should substantiate these findings at other sites.
- Open Access
- 29 July 2024
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 68 (5) , e373-e381
Start of the COVID-19 Pandemic and Palliative Care Unit Utilization: A Retrospective Cohort Study
- 29 July 2024
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 68 (5) , e373-e381
Open AccessStart of the COVID-19 Pandemic and Palliative Care Unit Utilization: A Retrospective Cohort Study
- Open Access
- 19 March 2024
- Published by Springer Nature in Diagnostic and Prognostic Research
- Vol. 8 (1) , 1-12
Study protocol for the development and validation of a clinical prediction tool to estimate the risk of 1-year mortality among hospitalized patients with dementia
Background: Patients with dementia and their caregivers could benefit from advance care planning though may not be having these discussions in a timely manner or at all. A prognostic tool could serve as a prompt to healthcare providers to initiate advance care planning among patients and their caregivers, which could increase the receipt of care that is concordant with their goals. Existing prognostic tools have limitations. We seek to develop and validate a clinical prediction tool to estimate the risk of 1-year mortality among hospitalized patients with dementia. Methods: The derivation cohort will include approximately 235,000 patients with dementia, who were admitted to hospital in Ontario from April 1st, 2009, to December 31st, 2017. Predictor variables will be fully prespecified based on a literature review of etiological studies and existing prognostic tools, and on subject-matter expertise; they will be categorized as follows: sociodemographic factors, comorbidities, previous interventions, functional status, nutritional status, admission information, previous health care utilization. Data-driven selection of predictors will be avoided. Continuous predictors will be modelled as restricted cubic splines. The outcome variable will be mortality within 1 year of admission, which will be modelled as a binary variable, such that a logistic regression model will be estimated. Predictor and outcome variables will be derived from linked population-level healthcare administrative databases. The validation cohort will comprise about 63,000 dementia patients, who were admitted to hospital in Ontario from January 1st, 2018, to March 31st, 2019. Model performance, measured by predictive accuracy, discrimination, and calibration, will be assessed using internal (temporal) validation. Calibration will be evaluated in the total validation cohort and in subgroups of importance to clinicians and policymakers. The final model will be based on the full cohort. Discussion: We seek to develop and validate a clinical prediction tool to estimate the risk of 1-year mortality among hospitalized patients with dementia. The model would be integrated into the electronic medical records of hospitals to automatically output 1-year mortality risk upon hospitalization. The tool could serve as a trigger for advance care planning and inform access to specialist palliative care services with prognosis-based eligibility criteria. Before implementation, the tool will require external validation and study of its potential impact on clinical decision-making and patient outcomes. Trial registration: NCT05371782.
- 19 March 2024
- Published by Springer Nature in Diagnostic and Prognostic Research
- Vol. 8 (1) , 1-12
Open AccessStudy protocol for the development and validation of a clinical prediction tool to estimate the risk of 1-year mortality among hospitalized patients with dementia
Background: Patients with dementia and their caregivers could benefit from advance care planning though may not be having these discussions in a timely manner or at all. A prognostic tool could serve as a prompt to healthcare providers to initiate advance care planning among patients and their caregivers, which could increase the receipt of care that is concordant with their goals. Existing prognostic tools have limitations. We seek to develop and validate a clinical prediction tool to estimate the risk of 1-year mortality among hospitalized patients with dementia. Methods: The derivation cohort will include approximately 235,000 patients with dementia, who were admitted to hospital in Ontario from April 1st, 2009, to December 31st, 2017. Predictor variables will be fully prespecified based on a literature review of etiological studies and existing prognostic tools, and on subject-matter expertise; they will be categorized as follows: sociodemographic factors, comorbidities, previous interventions, functional status, nutritional status, admission information, previous health care utilization. Data-driven selection of predictors will be avoided. Continuous predictors will be modelled as restricted cubic splines. The outcome variable will be mortality within 1 year of admission, which will be modelled as a binary variable, such that a logistic regression model will be estimated. Predictor and outcome variables will be derived from linked population-level healthcare administrative databases. The validation cohort will comprise about 63,000 dementia patients, who were admitted to hospital in Ontario from January 1st, 2018, to March 31st, 2019. Model performance, measured by predictive accuracy, discrimination, and calibration, will be assessed using internal (temporal) validation. Calibration will be evaluated in the total validation cohort and in subgroups of importance to clinicians and policymakers. The final model will be based on the full cohort. Discussion: We seek to develop and validate a clinical prediction tool to estimate the risk of 1-year mortality among hospitalized patients with dementia. The model would be integrated into the electronic medical records of hospitals to automatically output 1-year mortality risk upon hospitalization. The tool could serve as a trigger for advance care planning and inform access to specialist palliative care services with prognosis-based eligibility criteria. Before implementation, the tool will require external validation and study of its potential impact on clinical decision-making and patient outcomes. Trial registration: NCT05371782.